PT  - JOURNAL ARTICLE
AU  - Kannian, Priya
AU  - Mahanathi, Pasuvaraj
AU  - Ashwini, Veeraraghavan
TI  - Concentration of the cellular material in the nasopharyngeal swabs increases the clinical sensitivity of SARS-CoV2 RT-PCR
AID  - 10.1101/2020.10.31.20218958
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.31.20218958
4099  - http://medrxiv.org/content/early/2020/11/04/2020.10.31.20218958.short
4100  - http://medrxiv.org/content/early/2020/11/04/2020.10.31.20218958.full
AB  - Severe acute respiratory syndrome - coronavirus 2 (SARS-CoV2) is detected by a highly sensitive molecular method, reverse transcriptase-polymerase chain reaction (RT-PCR) from nasopharyngeal swab (NPS) samples collected in 2-3ml of viral transport medium (VTM). Unlike body fluids, NPS samples are undermined by high variability in the amount of cells that get suspended into the VTM. Hence, the cell density used for RNA extraction becomes an important analytical variable that contributes to the overall sensitivity of the RT-PCR. In this study, we compared the sensitivity of SARS-CoV2 RT-PCR in 50 NPS samples collected from in-patients of the COVID wards using the concentration and direct methods. The concentration method detected the viral RNA in all 50 samples, while the direct method was positive in only 41 (82%) samples (p=0.003). Additionally, the Ct values were lower in the direct method compared to concentration method among the 41 positive samples (p=0.03 for N gene and p=0.04 for RdRp gene). The mean CV% was also ≥10%. Thus, the concentration of the cells prior to RNA extraction drastically improves the sensitivity of detection of SARS-CoV2 in NPS samples.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was funded by intramural research funds of The Voluntary Health Services Hospital, Chennai, India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was given exemption / waiver from full borad review by the Institutional Ethics Committee of The Voluntary Health Services, where this study was conducted. The IEC of VHS is approved by the Drug Controller General of India, Govt. Of India to oversee and monitor all clinical research of the institution including drug trials.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable